Post-Doctoral Research Fellow, Brigham and Women's Hospital
BIOGRAPHY
Unveiling Novel Biomarkers and their Spatial Distribution within the Tumor Microenvironment of Renal Cell Carcinoma Using the BOND RX and Image Analysis Workflow
Speaker
Event Date & Time
Date: October 2, 2024
Time: 8:00 AM PDT, 10:00 AM CDT, 11:00 AM EDT
Abstract
In this webinar, discover how Dr El Ahmar utilizes the BOND RX autostainer and image analysis workflow to stain formalin-fixed paraffin-embedded (FFPE) clinical trial samples with multiplex immunofluorescent assays. The aim is to reveal predictive biomarkers for response and resistance to immunotherapy and analyze their spatial distribution within the tumor microenvironment of renal cell carcinoma.
Dr El Ahmar will be presenting published laboratory work.
Learning Objectives
- Learn how academic labs are utilizing the BOND RX to understand the tumor microenvironment and find predictive biomarkers in Renal Cell Carcinoma
- See how researchers optimize multiplex immunofluorescent panels on the BOND RX using Opal
- Review 3 independent clinical trials on biomarker response to anti-PD-1 monotherapy
FOR RESEARCH USE ONLY.
Not For Use In Diagnostic Procedures. Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 27, 2024 | 9:00 AM
Join Dr. Emily Hodges, assistant professor of biochemistry at Vanderbilt University, to learn more about how the Hodges Lab is utilizing the 6-base genome to investigate the dynamics of enha...
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...
APR 15, 2024 | 12:00 AM
C.E. CREDITS
Every area of the laboratory has specific issues with pre-analytical errors causing unreadable or false results on samples, from mislabeling to samples being forgotten on the floors to drawi...
MAR 28, 2024 | 10:00 AM
Digital SPR (dSPR) is a next-generation technology for characterizing biomolecular interactions. By combining digital microfluidics (DMF) with localized SPR (LSPR), digital SPR systems can e...
Loading Comments...
Finish Registering
-
OCT 02, 2024Cancer Research & Oncology Virtual Event Series 2024 -
OCT 04, 2024The Thomas Experts Series & The Thomas Center Labs
-
OCT 16, 2024Cell & Gene Therapy Virtual Event Series 2024
- See More
